sábado, 16 de septiembre de 2023

Microbiome: Household environment and animal fecal contamination are critical modifiers of the gut microbiome and resistome in young children from rural Nicaragua

https://microbiomejournal.biomedcentral.com/

Featured Series: New Therapeutic Approaches for Rare Diseases

https://ojrd.biomedcentral.com/https://ojrd.biomedcentral.com/

NCI clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma

https://www.cancer.gov/news-events/press-releases/2022/nci-trial-atezolizumab-approval-alveolar-soft-part-sarcoma

NCI Minute: Immunotherapy for a Rare Cancer

FDA Issues Warning Letters to Three Infant Formula Manufacturers

https://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-three-infant-formula-manufacturers?utm_medium=email&utm_source=govdelivery FDA Issues Warning Letters to Three Infant Formula Manufacturers Actions are Part of Enhanced Oversight; FDA Does Not Advise Discarding or Avoiding Purchase of Any Particular Infant Formula The U.S. Food and Drug Administration issued warning letters to three infant formula manufacturers as part of the agency’s ongoing commitment to enhance regulatory oversight to help ensure that the industry is producing infant formula under the safest conditions possible.

OBC Group Corp Recalls Nuez de la India Seeds and Capsules Products Due to Possible Health Risks

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/obc-group-corp-recalls-nuez-de-la-india-seeds-and-capsules-products-due-possible-health-risks?utm_medium=email&utm_source=govdelivery OBC Group Corp Retira Del Mercado Productos De Semillas Y Cápsulas De Nuez De La India Debido A Posibles Riesgos Para La Salud OBC GROUP CORP de, Miami, FL está retirando del mercado sus semillas y cápsulas NUT DIET MAX Nuez de la India porque un análisis de la FDA ha determinado que los productos parecen ser Thevetia peruviana o adelfa amarilla. Se sabe que todas las partes de la planta de adelfa amarilla contienen glucósidos cardíacos que son altamente tóxicos para humanos y animales. La ingestión de adelfa amarilla puede causar efectos adversos de salud neurológicos, gastrointestinales y cardiovasculares que pueden ser graves o incluso fatales. Los síntomas pueden incluir náuseas, vómitos, mareos, diarrea, dolor abdominal, cambios del ritmo cardíaco, arritmia y más. Las semillas se distribuyeron en línea a través de las plataformas Amazon y eBay. El producto viene en una bolsa transparente de 2 onzas. Las cápsulas de NUEZ DE LA INDIA se distribuyeron en línea a través de las plataformas Ebay y Walmart. Las cápsulas vienen en un frasco ámbar con 30 cápsulas.

FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants

FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants https://www.fda.gov/news-events/press-announcements/fda-takes-action-updated-mrna-covid-19-vaccines-better-protect-against-currently-circulating?utm_medium=email&utm_source=govdelivery FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants The U.S. Food and Drug Administration took action approving and authorizing for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death. Today’s actions relate to updated mRNA vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer Inc. Consistent with the totality of the evidence and input from the FDA’s expert advisors, these vaccines have been updated to include a monovalent (single) component that corresponds to the Omicron variant XBB.1.5.